Your SlideShare is downloading. ×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Pain Management Devices Market Forecast 2014 2024

454
views

Published on

For an Executive Summary of this report please contact ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976) or refer to our website …

For an Executive Summary of this report please contact ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976) or refer to our website https://www.visiongain.com/Report/1286/Pain-Management-Devices-Market-Forecast-2014-2024

Published in: Business, Health & Medicine

0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
454
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
16
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Pain Management Devices Market Forecast 2014-2024 Future Prospects for Leading Companies ©notice This material is copyright by visiongain. It is against the law to reproduce any of this material without the prior written agreement of visiongain.You cannot photocopy, fax, download to database or duplicate in any other way any of the material contained in this report. Each purchase and single copy is for personal use only.
  • 2. www.visiongain.com Contents 1.1 Global Pain Management Devices Market Overview 1.2 Global Pain Management Devices Market Segmentation 1.3 Why You Should Read This Report 1.4 How This Report Delivers 1.5 Key Questions Answered by This Analytical Report 1.6 Who is This Report For? 1.7 Methodology 1.8 Frequently Asked Questions (FAQ) 1.9 Associated Reports 1.10 About Visiongain 2.1 Pain: A Sensory And Emotional Phenomenon 2.1.1 Pain: A Short History 2.1.2 Pain Pathways And The Origin Of Pain 2.2 The World Health Organisation (WHO) Pain Ladder 2.2.1 Classification Of Pain 2.2.1.1 Acute Pain 2.2.1.2 Chronic Pain 2.3 The Psychosocial Effects Of Chronic Pain 2.3.1 Chronic Cancer Pain 2.3.2 Neuropathic Pain 2.3.3 Identifying Neuropathic Pain 2.4 The Neurochemistry Of Pain 2.4.1 Prostaglandins 2.4.2 Opioids 2.5 Pain Management – A Brief Overview 1. Report Overview 2. An Introduction to Pain and Pain Management
  • 3. www.visiongain.com Contents 2.6 Pain Management Drugs 2.6.1 The Use Of Opioids In Pain Management 2.6.2 OTC Pain Relievers 2.7 Pain Management Devices 2.7.1 Radiofrequency Ablation Devices 2.7.2 Analgesic Pumps 2.7.2.1 Types Of Infusion 2.7.2.2 Advantages And Disadvantages Of Infusion Pumps 2.7.3 Intradiscal Electrothermal Therapy 2.7.4 Neurostimulation 2.7.4.1 Spinal Cord Stimulation 2.7.4.2 Deep Brain Stimulation 2.7.4.3 Occipital Nerve Stimulation 2.7.5 Microcurrent Electrical Neuromuscular Stimulation 2.7.6 Transcutaneous Electrical Nerve Stimulation 2.8 Medical Devices Classification Systems 2.8.1 The US Medical Devices Classification System 2.8.2 The EU Medical Devices Classification System 2.9 Regulation Of Medical Devices 2.9.1 The US Approval And Regulation System 2.9.2 The EU Approval And Regulation System 2.9.2.1 Post-Marketing Surveillance In The EU 2.10 Market Definition 3.1 The Global Pain Management Market In 2013 3.2 Pain Management Devices: Global Market Overview 3. The Global Pain Management Devices Market: By Device Type, 2014-2024
  • 4. www.visiongain.com Contents 3.2.1 The Global Pain Management Devices Market In 2013 3.2.2 Global Pain Management Devices: Market Forecast 2014-2024 3.2.3 Changing Market Shares By Sector 2014-2024 3.3 Analgesia Infusion Pumps Market 2014-2024 3.3.1 Intrathecal Drug Delivery Systems 3.3.2 Patient Controlled Analgesia 3.3.2.1 Costs And Benefits Of PCA Pumps 3.3.2.2 PCA Pumps: Leading Products, 2014 3.3.3 Analgesia Infusion Pumps: Market Forecast 2014-2024 3.4 Spinal Cord Stimulation Market 2014-2024 3.4.1 Spinal Cord Stimulation: Leading Products, 2014 3.4.2 Spinal Cord Stimulation For Pain Management: Market Forecast 2014-2024 3.5 Radiofrequency Ablation Market 2014-2024 3.5.1 Radiofrequency Ablation for Pain Management: Leading Products, 2014 3.5.2 Radiofrequency Ablation for Pain Management: Market Forecast 2014-2024 3.6 Intradiscal Electrothermal Therapy 2014-2024 3.6.1 Intradiscal Electrothermal Therapy for Pain Management: Market Forecast 2014-2024 3.7 Transcutaneous Electrical Nerve Stimulation 2014-2024 3.7.1 Transcutaneous Electrical Nerve Stimulation: Leading Products, 2014 3.7.2 Transcutaneous Electrical Nerve Stimulation For Pain Management: Market Forecast 2014-2024 3.8 Microcurrent Electrical Neuromuscular Stimulation 2014-2024 3.8.1 Microcurrent Electrical Neuromuscular Stimulation For Pain Management: Market Forecast 2014-2024 3.9 Other Pain Management Devices 2014-2024 3.9.1 Occipital Nerve Stimulation As A Pain Management Therapy 3.9.2 Deep Brain Stimulation As A Pain Management Therapy 3.9.3 Other Pain Management Devices: Market Forecast 2014-2024
  • 5. www.visiongain.com Contents 4.1 Chronic Pain: Variable Causes And Related Conditions 4.2 Pain Management Devices: Applications and Uses 4.2.1 Pain Management Devices Market By Application In 2013 4.2.2 Global Pain Management Devices By Application: Market Forecast 2014-2024 4.2.3 Changing Market Shares By Application 2014-2024 4.3 Musculoskeletal Pain Management Devices Market 2014-2024 4.3.1 Musculoskeletal Pain Management Devices: Leading Products, 2014 4.3.2 Musculoskeletal Pain Management Devices: Market Forecast 2014-2024 4.4 Cancer Pain Management Devices Market 2014-2024 4.4.1 Cancer Pain Management Devices: Leading Products, 2014 4.4.2 Cancer Pain Management Devices: Market Forecast 2014-2024 4.5 Migraine and Facial Pain Management Devices Market 2014-2024 4.5.1 Migraine Relieving Techniques 4.5.2 Migraine Pain Management Devices: Leading Products, 2014 4.5.3 Migraine And Facial Pain Management Devices: Market Forecast 2014-2024 4.6 Neuropathic Pain Management Devices Market 2014-2024 4.6.1 Neuropathic Pain Management Devices: Leading Products, 2014 4.6.2 Neuropathic Pain Management Devices: Market Forecast 2014-2024 4.7 Surgical And Trauma Pain Management Devices Market 2014-2024 4.7.1 Surgical And Trauma Pain Management Devices: Leading Products, 2014 4.7.2 Surgical And Trauma Pain Management Devices: Market Forecast 2014-2024 4.8 The Market For Other Pain Management Devices 2014-2024 4.8.1 The Market For Other Pain Management Devices: Market Forecast 2014-2024 4. The Global Pain Management Devices Market: By Application, 2014-2024
  • 6. www.visiongain.com Contents 5.1 The Pain Management Devices Market By Region 5.1.1 The Global Distribution Of Pain Management Devices In 2013 5.2 Leading National Markets: Forecast, 2014-2024 5.2.1 Changing Market Shares By Region, 2014-2024 5.3 Regional Pain Management Devices Markets: Analysis and Forecasts, 2014-2024 5.4 United States: The Largest Pain Management Devices Market 5.5 The EU5 Markets 5.5.1 EU5 Markets: Changing Market Shares by Country, 2014-2024 5.5.2 Germany: Fiscal Austerity Programs And Spending Cuts Impacting Market Growth 5.5.3 France: Price Reductions And Lowering Consumption Are Concerns For Market Growth 5.5.4 UK: Private Patient Income Will Help To Offset Low Funding Levels 5.5.5 Italy: Restrictions On The Use Of Analgesic Drugs To Help Boost Pain Devices 5.5.6 Spain: Rationalisation Of Health And Pharmaceutical Expenditure Limiting Market Growth 5.6 China: Shifting Technological Landscape Will Drive Market Growth 5.7 Japan: An Ageing Population Coupled With The Fear Of Opioid Addiction Will Stimulate Pain Devices Uptake 5.8 India: Rising Pain Incidence And Improving Socio-Economic Conditions 5.9 South Korea: Universal Healthcare Coverage And Government Investment Fuelling Market Growth 5.10 Russia: Improving Market Penetration For Pain Devices 5.11 Brazil: Inadequate Infrastructure Limiting Expansion 5.12 Mexico: Heavy Regulation Of Opioid Use To Strengthen Device Uptake 5.13 Rest Of The World 5. Leading National Pain Management Devices Markets 2014-2024
  • 7. www.visiongain.com Contents 6.1 Pain Management Devices – A Diversified Market 6.2 BioDelivery Sciences International (BDSI) 6.2.1 BDSI - The BEMA Technology Platform 6.2.2 BDSI: Historical Revenue Analysis, 2009-2013 6.3 Boston Scientific 6.3.1 Boston Scientific: Revenue Analysis, 2013 6.3.2 Boston Scientific - Precision And Precision Spectra Spinal Cord Stimulation Systems 6.3.3 GUIDE DBS And Enspire DBS Systems - Intelect Medical/Boston Scientific 6.4 Cephalon (Teva Pharmaceuticals) 6.4.1 Cephalon’s Pain Management Products 6.4.1.1 Actiq – Cephalon’s Therapy For Cancer Pain 6.5 DJO Global (Empi Inc) 6.5.1 Empi Inc 6.5.2 Empi’s Electrotherapy Products 6.5.3 Empi’s Iontophoresis Patch Systems 6.6 Endo Pharmaceuticals 6.6.1 Endo Pharmaceuticals: Historical Revenue Analysis, 2011-2013 6.6.2 Endo Pharmaceuticals Pain Management – Lidoderm 6.7 Hospira 6.7.1 Hospira: Historical Revenue Analysis, 2009-2013 6.7.2 Hospira - LifeCare PCA Infusion System 6.8 Kimberly-Clark Health Care 6.8.1 Kimberly-Clark: Revenue Analysis 6.8.2 Kimberly-Clark’s Cooled Radiofrequency System for Chronic Pain Relief 6.9 Medtronic 6.9.1 Medtronic: Historical Revenue Analysis, 2013-2014 6. Leading Companies in the Pain Management Devices Market, 2014
  • 8. www.visiongain.com Contents 6.9.2 Medtronic Pain Management Products 6.9.2.1 RestoreSensor Neurostimulator 6.9.2.2 RestoreUltra Neurostimulator 6.9.2.3 SynchroMed II Drug Pump 6.10 Pain Management Technologies Inc 6.10.1 Pain Management Technologies Inc’s Products 6.11 St Jude Medical 6.11.1 St Jude Medical: Historical Revenue Analysis, 2009-2013 6.11.2 St Jude Medical: Pain Management Products 6.11.3 Axium Neurostimulator System – SJM and Spinal Modulation 7.1 Peripheral Nerve Stimulation – Pipeline Products 7.1.1 Altius System High Frequency Nerve Block (Neuros Medical) 7.1.2 MicroStim System (MicroTransponder Inc) 7.1.3 Senza SCS System (Nevro Corporation) 7.2 Analgesic Infusion Systems – Pipeline Products 7.2.1 Programmable Implantable DDS (Palyon Medical Corporation) 7.2.2 Zalviso (AcelRx Pharmaceuticals) 7.3 Occipital Nerve Stimulation – Pipeline Products 7.3.1 Precision System (Boston Scientific) 7.4 Radiofrequency Ablation – Pipeline Products 7.4.1 Intracept (Relievant Medsystems Inc) 8.1 SWOT Analysis Of The Pain Management Devices Market, 2014-2024 8.1.1 Strengths 7. Pain Management Devices: R&D Pipeline 2014-2024 8. Qualitative Analysis of the Pain Management Devices Market, 2014-2024
  • 9. www.visiongain.com Contents 8.1.1.1 Cost Effectiveness: A Central Driver For Growth 8.1.1.2 Positive Side Effect Profile Of Pain Management Devices Compared With Pain Relieving Drugs 8.1.2 Weaknesses 8.1.2.1 Short Term Pain Relief 8.1.2.2 Mechanisms Of Action Not Fully Understood 8.1.2.3 Lack Of Evidence To Support The Efficacy And Safety Of Some Therapies 8.1.2.4 Devices Failing In Clinical Trials 8.1.2.5 Education In Pain Management Is A Key Unmet Need 8.1.3 Opportunities 8.1.3.1 Expanding Disease Indications Driving Neurostimulation for Pain Relief 8.1.3.2 The Potential Of Personalised Medicine 8.1.3.3 Expansion Into Emerging Markets 8.1.3.4 Ageing Population – Growth Driver For Pain Management 8.1.4 Threats 8.1.4.1 Increasing Regulatory And Pricing Scrutiny 8.1.4.2 Medical Device Excise Tax: A Drain On Innovation? 8.1.4.3 Inadequate Reimbursement Levels Limits Potential Of Pain Devices 8.2 Porter’s Five Force Analysis Of The Pain Management Device Market 8.2.1 Threat Of Substitutes: High 8.2.2 Power Of Suppliers: Medium 8.2.3 Rivalry Among Competitors: Medium 8.2.4 Bargaining Power Of Buyers: High 8.2.5 Threat Of New Entrants: Medium 9.1 Interview With Dr Deepak Kotak, Executive Vice President, BioElectronics Corporation 9.1.1 Pain Management Devices: Market Stratification And Brief History 9.1.2 On The Direct And Related Costs Of Pain And Pain Management 9. Expert Opinions
  • 10. www.visiongain.com Contents 9.1.3 BioElectronics’ Products – FDA Approvals And The Quest For OTC Status 9.1.4 BioElectronic’s Product Distribution Partnerships And Entry Into The Advanced Wound Care Markets 9.1.5 On The Future Plans For Product Launch 9.1.6 The Issue Of Efficacy And Healthcare Economics And Their Impact On Pain Management Devices 9.1.7 On Future Technological Developments – Vagal Nerve And Trigeminal Nerve Stimulation 9.1.8 On The Future Challenges And Opportunities Facing Pain Management Devices Over The Next Decade 9.2 Interview With Penney Cowan, Chief Executive Officer, American Chronic Pain Association 9.2.1 On The Current State Of The Pain Management Devices Market 9.2.2 Socio-Political Influences On Pain Management Device And The Current Trends In The Market 9.2.3 ACPA’s Role In Patient Empowerment And Pain Management 9.2.4 ACPA’s Corporate Strategy And Future Plans 9.2.5 On The Misconceptions Surrounding Pain And Pain Management 9.2.6 On Factors That Will Affect Future Technology Developments In Pain Management 9.2.7 Interdisciplinary Pain Management As An Opportunity For Market Growth 10.1 Market Overview 10.2 Commercial Drivers For Pain Management Devices 10.3 Neuromodulation Looks Set For High Growth 10.4 Rising Demand From Musculoskeletal Pain Will Drive Market Growth 10.5 Leading Developers Of Pain Management Devices 10.6 Growth Concentrated In The Developed Markets Of North America And Europe 10.7 Future Prospects For Pain Management Devices 10. Conclusion
  • 11. Page 72www.visiongain.com Pain Management Devices Market Forecast 2014-2024: Future Prospects for Leading Companies Figure 3.10 Analgesia Infusion Pumps Market: Market Forecast ($m, AGR%), 2013- 2024 Table 3.9 Analgesia Infusion Pumps Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Analgesia Infusion pumps ($m) 1125.0 1181.3 1240.3 1302.3 1380.5 1477.1 1580.5 1659.5 1759.1 1864.6 2013.8 2174.9 AGR (%) 5.0 5.0 5.0 6.0 7.0 7.0 5.0 6.0 6.0 8.0 8.0 CAGR (%) 2013-18 CAGR (%) 2013-24 5.6 2018-24 6.7 6.2 A number of novel pain relieving medications are currently in the pipeline. Many of these drugs may be reformulated in the long run for use with infusion pumps. As will many of the currently available narcotics and pain relieving drugs. There are growth opportunities in the emerging economies that still rely on gravity infusions, which do not meet the precision level of the infusion pumps. Improvements in the healthcare infrastructure in these developing regions will drive the 0 1 2 3 4 5 6 7 8 9 0 500 1000 1500 2000 2500 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 AGR(%) MarketSize($m) Year Market Size ($m) AGR (%) Source: Visiongain 2014 Source: Visiongain 2014
  • 12. Page 112www.visiongain.com Pain Management Devices Market Forecast 2014-2024: Future Prospects for Leading Companies stimulation (PENS) is geared towards controlling refractory neuropathic pain. This procedure is similar to TENS, but it involves the insertion of electrode needles underneath the skin. The inserted needles are connected to a stimulator device with the appropriate settings. As procedures such as this begin to gain popularity and acceptance, visiongain forecasts the market for neuropathic pain management devices to continue its growth to 2024, when the market will reach $1178.0m, with CAGR of 10.7% between 2018 and 2024 (Table 4.13 and Figure 4.13). Figure 4.13 Neuropathic Pain Management Devices Market: Market Forecast ($m, AGR%), 2013-2024 Table 4.13 Neuropathic Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Neuropathic ($m) 434.8 469.6 507.2 542.7 586.1 638.9 696.4 755.5 831.1 922.5 1042.4 1178.0 AGR (%) 8.0 8.0 7.0 8.0 9.0 9.0 8.5 10.0 11.0 13.0 13.0 CAGR (%) 2013-18 CAGR (%) 2013-24 8.0 2018-24 10.7 9.5 0 2 4 6 8 10 12 14 0 200 400 600 800 1000 1200 1400 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 AGR(%) MarketSize($m) Year Market Size ($m) AGR (%) Source: Visiongain 2014 Source: Visiongain 2014
  • 13. Page 135www.visiongain.com Pain Management Devices Market Forecast 2014-2024: Future Prospects for Leading Companies Table 5.11 The German Pain Management Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024 2013 2018 2024 Market Size ($m) 255.1 351.1 569.4 Global Market Ranking 2nd 2nd 3rd EU5 Market Share (%) 31.6 31.0 29.9 2013-2024 CAGR (%) Market Outlook 2013-2024 7.6 Positive Germany remains the biggest exporter of medical devices in Europe. This capability coupled with the improving economic conditions being witnessed in certain Western European countries including Germany will aid the growth of the pain management devices market in Germany. Visiongain forecasts this market to rise from $255.1m in 2013, to $569.4m in 2018, with CAGR of 7.6% between 2013 and 2024 (Table 5.12 and Figure 5.16). Germany remains an attractive export market to innovative drug and device developers. The market has witnessed a recent boost in the manufacturing of drugs and devices geared towards acute conditions such as rheumatoid arthritis, cancer, and multiple sclerosis. Germany also remains a major market for therapies used in the treatment of chronic conditions such as diabetes and cardiovascular diseases, due to the rise in the ageing population being seen across Western Europe in general. Visiongain notes that these factors will play a role in boosting sales of pain management devices in Germany over the forecast period. Table 5.12 The German Pain Management Devices Market: Market Forecast ($m, AGR%, CAGR%), 2013-2024 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 German Market ($m) 255.1 271.6 287.9 305.2 326.6 351.1 377.4 401.9 436.1 477.5 522.5 569.4 AGR (%) 6.5 6.0 6.0 7.0 7.5 7.5 6.5 8.5 9.5 9.4 9.0 CAGR (%) 2013-18 CAGR (%) 2013-24 6.6 2018-24 8.4 7.6 Source: Visiongain 2014 Source: Visiongain 2014